Copy to clipboard
CopyClarke, NW ;
Ali, A ;
Ingleby, FC Hoyle, A ;
Amos, CL ;
Attard, G ;
Brawley, CD ;
Calvert, J ;
Chowdhury, S ;
Cook, A ;
+41 more...
Cross, W ;
Dearnaley, DP ;
Douis, H ;
Gilbert, D ;
Gillessen, S ;
Jones, RJ ;
Langley, RE ;
MacNair, A ;
Malik, Z ;
Mason, MD ;
Matheson, D ;
Millman, R ;
Parker, CC ;
Ritchie, AWS ;
Rush, H ;
Russell, JM ;
Brown, J ;
Beesley, S ;
Birtle, A ;
Capaldi, L ;
Gale, J ;
Gibbs, S ;
Lydon, A ;
Nikapota, A ;
Omlin, A ;
O'Sullivan, JM ;
Parikh, O ;
Protheroe, A ;
Rudman, S ;
Srihari, NN ;
Simms, M ;
Tanguay, JS ;
Tolan, S ;
Wagstaff, J ;
Wallace, J ;
Wylie, J ;
Zarkar, A ;
Sydes, MR ;
Parmar, MKB ;
James, ND ;
STAMPEDE investigators ;
(2020)
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003.
ANNALS OF ONCOLOGY, 31 (3).
442-.
ISSN 0923-7534
DOI: https://doi.org/10.1016/j.annonc.2020.01.002
